Precigen
PGEN
#5417
Rank
โ‚ฌ1.35 B
Marketcap
3,79ย โ‚ฌ
Share price
-2.58%
Change (1 day)
-9.55%
Change (1 year)

Earnings for Precigen (PGEN)

Earnings in 2026 (TTM): โ‚ฌ22.47 Million

According to Precigen's latest financial reports the company's current earnings are โ‚ฌ0.15 Billion. In 2025 the company made an earning of -โ‚ฌ0.23 Billion a decrease over its 2024 earnings that were of -โ‚ฌ0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Precigen from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ22.47 M-109.85%
2025 -โ‚ฌ0.23 Billion95.77%
2024 -โ‚ฌ0.12 Billion32.86%
2023 -โ‚ฌ87.75 Million20.5%
2022 -โ‚ฌ72.82 Million-23.33%
2021 -โ‚ฌ94.98 Million60.11%
2020 -โ‚ฌ59.32 Million-65.1%
2019 -โ‚ฌ0.17 Billion-65.19%
2018 -โ‚ฌ0.49 Billion313.44%
2017 -โ‚ฌ0.12 Billion-33.2%
2016 -โ‚ฌ0.18 Billion123.22%
2015 -โ‚ฌ79.21 Million1.47%
2014 -โ‚ฌ78.06 Million109.54%
2013 -โ‚ฌ37.26 Million-50.04%
2012 -โ‚ฌ74.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-โ‚ฌ2.27 Million-110.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-โ‚ฌ66.53 Million-396.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚ฌ0.21 Billion-1,008.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-โ‚ฌ81.92 Million-465.61% Jersey